- Reactogenicity to COVID-19 vaccination in the United States of America
-
Sanyaolu A, Marinkovic A, Prakash S, Desai P, Haider N, Abbasi AF, Mehraban N, Jain I, Ekeh A, Shazley O, Okorie C, Orish VN
- KMID: 2534933
- Clin Exp Vaccine Res.
- 2022 Jan;11(1):104-115.
- doi: 10.7774/cevr.2022.11.1.104
Purpose In the United States, Pfizer-BioNTech, Moderna, and Janssen’s coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food... -
- CITED
-
- Close
- SHARE
-
- Close
